中国药业2017，Vol.26Issue(1)：80-81,2.DOI:10.3969/j.issn.1006-4931.2017.01.026
我国药品经营企业对供应商质量审计的现状及改进措施探讨
Consideration on Quality Audit of Suppliers in China's Pharmaceutical Enterprises and Improvement Measures
张少兰1
作者信息
- 1. 重庆医药 ﹤ 集团 ﹥ 股份有限公司，重庆 400010
- 折叠
摘要
Abstract
Objective To promote quality auditing of drug suppliers in China and to ensure the drug quality. Methods With reference to the 2012 edition of Quality Management Standard for Drug Administration, this paper discussed the quality audit of pharmaceutical suppliers, the status quo and problems, improvement measures and so on. Results and Conclusion The quality audit of drug suppliers in China is still insufficient. It is necessary to strengthen the management of suppliers, optimize the supply chain channels to ensure the stability and consistency of drug quality control.关键词
药品经营企业/质量审计/资质/药品经营质量管理规范/现场质量审计Key words
pharmaceutical enterprise/quality audit/qualification/GSP/on-site quality audit分类
医药卫生引用本文复制引用
张少兰..我国药品经营企业对供应商质量审计的现状及改进措施探讨[J].中国药业,2017,26(1):80-81,2.
